1. Introduction {#s0005}
===============

Coronaviruses are enveloped positive-sense RNA viruses which have crown-like appearance under the electron microscope and usually ranges from 60 to 140 nm in diameter ([@b0080]). There are four coronaviruses (OC43, 229E, NL63 and HKU1) which cause mild respiratory distress in humans ([@b0085]). The cross-species transmission of animal beta coronaviruses to humans have been reported since last two decades-the first event which occurred in 2002--2003 when the bat originated coronaviruses crossed over to humans via palm civet cats as intermediary host and caused severe respiratory syndrome (SARS) in humans and was known as SARS coronaviruses (SARS-CoV) which infected 8422 people in China and Hong Kong and caused 916 deaths with a mortality rate of 11% ([@b0015]). In 2012, almost a decade later, another bat-originated virus emerged in Saudi Arabia and the transmission to humans was via dromedary camels. The virus was designated as the Middle East respiratory syndrome coronavirus (MERS-CoV) which infected 2494 people and caused 858 deaths with fatality rate of 34% ([@b0085]). There is a recent global health emergency around the world with the rapid emergence and spread of 2019 novel coronavirus (2019-nCoV) or the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which has caused a pandemic known as coronavirus disease 2019 (COVID-19). The outbreak was first reported in Wuhan, Hubei province, China in December 2019 ([@b0115]). The intermediary hosts which led to the transmission of this bat-originated virus to humans is still an enigma. According to the WHO report, there has been 25, 49,632 confirmed cases of COVID-19 and 1, 75,825 confirmed deaths to date (23/04/2020) (Coronavirus disease Pandemic, 2020).

The coronaviruses (CoVs) RNA genome has a size ranging from 27 to 31 kb and it is the largest viral RNA genomes known to date ([@b0055]). The two overlapping polyproteins (pp1a and pp1ab) encoded by the CoV replicase gene are essential for viral replication and transcription ([@b0090], [@b0125]). These polyproteins need to undergo a complex cascade of proteolytic processing for maturation which in turn regulates viral gene expression and replication ([@b0120]). The enzyme CoV main protease (CoV M^pro^; also known as 3C-like protease or 3CL^pro^) catalyzes the most of the maturation cleavage events within the precursor polyproteins ([@b0065], [@b0130]). It is a three-domain (domains I to III) cysteine protease with a chymotrypsin-like fold at the N terminus and a Cys-His catalytic located in a cleft between domains I and II ([@b0005], [@b0125]). The CoV M^pro^ has emerged as an attractive drug target for anti-coronaviral drug design because of its vital role in the maturation and processing of the replicase polyprotein ([@b0120], [@b0130]). The enzyme has been targeted previously with antiviral phytochemicals ([@b0030], [@b0045], [@b0100]), marine natural products ([@b0020]) and FDA approved drugs ([@b0050], [@b0070]).

The lack of effective therapeutics against human coronaviral infections ([@b0025]) and the high mortality rates due to the recent emergence of novel coronavirus (2019-nCoV) have necessitated the discovery of new vaccines or drugs. In the present study, we have explored the possibility of the FDA approved drugs as potential inhibitors of M^pro^ enzyme which will help in halting the virus replication and curtail the progression of the disease. We have used molecular docking study to explore the binding interaction of the FDA approved drugs with three target enzymes (SARS-CoV M^pro^, SARS-CoV-2 M^pro^ and MERS-CoV M^pro^) and shortlisted suitable lead molecules for each target.

2. Materials and methods: {#s0010}
=========================

2.1. Retrieval and preparation of structures of FDA approved drugs: {#s0015}
-------------------------------------------------------------------

A set of 1390 chemical structures of FDA approved drugs were downloaded from ZINC 15 database ([@b0095]). The 3D structures of the molecules in SDF format were retrieved and the molecules having only 2D structure available were processed into 3D structures using Open Babel version 2.4.1 software ([@b0075]) and subsequently energy-optimized using MMFF force field ([@b0040]) following our previously described protocol ([@b0035]). The molecules were prepared for docking using AutoDock Toos-1.5.6 by the addition of Gasteiger charges and hydrogen atoms and torsions for each molecule were optimally defined. The structures of the compounds were saved in PDBQT format.

2.2. Retrieval and preparation of structures of target enzymes {#s0020}
--------------------------------------------------------------

The three-dimensional structures of the enzyme targets-SARS-CoV-2 M^pro^ (PDB ID: 6Y2F), SARS-CoV M^pro^ (PDB ID: 3TNT) and MERS-CoV M^pro^ (PDB ID: 5WKK) solved through high-resolution X-ray crystallographic technique at a resolution of 1.95 Å, 1.59 Å and 1.55 Å respectively were retrieved from Protein Data Bank (<http://www.rcsb.org/>). Each target enzyme was prepared by removing the heteroatoms including ions, co-crystallized ligands (O6Y, G85 and AW4 corresponding to PDB IDs: 6Y2F, 3TNT and 5WKK respectively) and water molecules. Further, an optimum number of polar hydrogen atoms and Kolmann charges were added to each protein target using AutoDock Toos-1.5.6 and the structures were saved in PDBQT format.

2.3. Evaluation of binding affinity of the compounds with the target enzymes {#s0025}
----------------------------------------------------------------------------

The binding affinity of each molecule along with the control inhibitors was evaluated against the three enzyme targets using molecular docking approach. The binding sites for the compounds were defined by choosing grid box of dimensions of 25 × 25 × 25 Å^3^ with exhaustiveness value of 8 centred at x:9.6421, y:−0.3396, z:18.3327; x:25.6069, y:44.4317, z:−5.6802 and x:−21.9764, y:24.4145, z:4.8599 of SARS-CoV-2 M^pro^, SARS-CoV M^pro^ and MERS-CoV M^pro^ respectively around the bound co-crystallized ligand. Autodock vina was used for performing molecular docking study which executes docking calculations based on sophisticated gradient optimization method ([@b0110]).

2.4. Evaluation of binding energy scores and study of binding poses {#s0030}
-------------------------------------------------------------------

The lowest binding energy score of each ligand was taken into account for studying their binding poses. The molecular interactions (hydrogen bonds and hydrophobic interactions) between the target proteins and compounds were studied using LigPlot + version 1.4.5 tool ([@b0060]).

3. Results and discussion {#s0035}
=========================

The binding affinities of a total of 1390 FDA approved drugs were tested against three enzyme targets-SARS-CoV-2 M^pro^, SARS-CoV M^pro^ and MERS-CoV M^pro^. The docking scores were benchmarked using three control inhibitors- α-ketoamide 13b (O6K), SG85 (G85) and GC813 (AW4). The top five lead molecules identified for SARS-CoV-2 M^pro^ were Dihydroergotamine (ZINC000003978005), Avodart (ZINC000003932831), Irinotecan (ZINC000001612996), Ergotamine (ZINC000052955754) and Olysio (ZINC000164760756) with binding energies of −9.4 kcal/mol, −9.3 kcal/mol, −9.3 kcal/mol, −9.3 kcal/mol and −9.2 kcal/mol respectively ([Table 1](#t0005){ref-type="table"} ). The best lead molecule Dihydroergotamine (ZINC000003978005) binds to a pocket within the Cys145-His41 dyad and exhibits two hydrogen bonds with backbone nitrogen (N) atom of Gly143 and the binding pose further shows the participation of nine residues (Thr25, His41, Cys44, Met49, Asn142, Cys145, His164, Met165 and Glu166) in hydrophobic interactions with SARS-CoV-2 M^pro^ ([Fig. 1](#f0005){ref-type="fig"} A). The control inhibitor, α-ketoamide 13b (O6K) scored binding energy of −6.9 kcal/mol with two hydrogen bonds-one with the side chain nitrogen (NE2) atom of His41 and the second one with the backbone nitrogen (N) atom of Glu166 and hydrophobic interactions via residues-Thr26, Met49, Cys145, His163, Met165, Pro168, Gln189 and Thr190 ([Fig. 1](#f0005){ref-type="fig"}B).Table 1Binding energy scores and molecular interactions between top 5 leads and SARS-CoV-2 M^pro^. The figures in bracket indicate the hydrogen bond length.ZINC IDCommon NameStructureBinding Energy (kcal/mol)Molecular InteractionsHydrogen bondsHydrophobic interactionsZINC000003978005Dihydroergotamine![](fx1_lrg.gif)−9.4O1.....N(Gly143) \[3.13 Å\]\
O4.....N(Gly143) \[2.80 Å\]Thr25, His41, Cys44, Met49, Asn142, Cys145, His164, Met165 and Glu166 (N = 9)ZINC000003932831Avodart![](fx2_lrg.gif)−9.3N1.....O(Gln192) \[3.29 Å\]\
F3.....NE2(His163) \[3.07 Å\]Leu141, Asn142, Gly143, Cys145, Met165, Glu166, Pro168, Arg188, Gln189 and Thr190 (N = 10)ZINC000001612996Irinotecan![](fx3_lrg.gif)−9.3N4.....O(Thr26) \[3.00 Å\]\
O3.....NE2(Gln192) \[2.90 Å\]Thr24, Thr25, His41, Met49, Asn119, Gly143, Cys145, His164, Met165, Glu166, Pro168, Gln189 and Thr190 (N = 13)ZINC000052955754Ergotamine![](fx4_lrg.gif)−9.3O4.....N(Gly143) \[3.13 Å\]Thr25, His41, Cys44, Met49, Asn142, Cys145, His164, Met165, Glu166, Asp187 and Arg188 (N = 11)ZINC000164760756Olysio![](fx5_lrg.gif)−9.2O6.....OG1 (Thr25) \[2.94 Å\]His41, Cys44, Thr45, Ser46, Met49, Phe140, Leu141, Asn142, Gly143, His163, His164, Met165, Glu166, Gln189 and Thr190 (N = 15)Control (O6K)α-ketoamide 13b![](fx6_lrg.gif)−6.9O26.....NE2(His41) \[3.10 Å\]\
O37.....N(Glu1660 \[3.23 Å\]Thr25, Met49, Cys145, His163, Met165, Pro168, Gln189 and Thr190 (N = 8)Fig. 1Binding conformation (compounds are represented as green sticks and key interacting residues are displayed in thin red wireframe representation) and molecular interaction between SARS-CoV-2 M^pro^ and (A) Dihydroergotamine (ZINC000003978005) (B) α-ketoamide 13b inhibitor (O6K). The hydrophobic interactions are indicated by red arcs with radiating spikes and green dashed lines correspond to hydrogen bonds.

For the second target-SARS-CoV M^pro^, the top 5 lead molecules identified were Saquinavir (ZINC000026985532), Ergotamine (ZINC000052955754), Nilotinib (ZINC000006716957), Raltegravir (ZINC000013831130) and Dihydroergotamine (ZINC000003978005) with binding energies of −9.6 kcal/mol, −9.5 kcal/mol, −9.4 kcal/mol, −9.2 kcal/mol and −9.2 kcal/mol respectively ([Table 2](#t0010){ref-type="table"} ). The best lead molecule- Saquinavir (ZINC000026985532) exhibits four hydrogen bonds (Three bonds with the backbone nitrogen (N) and oxygen (O) atom of Gly143, Leu141 and Glu166 and one hydrogen bond with side-chain oxygen (OE1) atom of Gln189) and twelve residues (Thr25, Thr26, His41, Met49, Phe140, Asn142, Cys145, His164, Met165, Leu167, Thr190 and Gln192) contributing to hydrophobic interactions with the target enzyme ([Fig. 2](#f0010){ref-type="fig"} A). The control, inhibitor SG85 (G85) of SARS-CoV M^pro^ exhibits binding energy of −7.9 kcal/mol with four hydrogen bonds (two hydrogen bonds with backbone N atoms of Cys145 and Glu166 and two hydrogen bonds with the side chain sulphur (SG) atom of Cys145 and side-chain oxygen (OE1) atom of Gln189) and hydrophobic interactions via sixteen residues (Thr25, Thr26, His41, Met49, Phe140, Leu141, Asn142, Gly143, Ser144, His163, His164, Met165, Asp187, Thr190, Ala191 and Gln192) ([Fig. 2](#f0010){ref-type="fig"}B).Table 2Binding energy scores and molecular interactions between top 5 leads and SARS-CoV M^pro^. The figures in bracket indicate the hydrogen bond length.ZINC IDCommon NameStructureBinding Energy (kcal/mol)Molecular InteractionsHydrogen bondsHydrophobic interactionsZINC000026985532Saquinavir![](fx7_lrg.gif)−9.6O6.....N(Glu166) \[2.83 Å\]\
N5.....OE1(Gln189) \[3.06 Å\]\
O2.....O(Leu141) \[2.75 Å\]\
O1.....N(Gly143) \[2.89 Å\]Thr25,Thr26, His41,Met49, Phe140, Asn142, Cys145, His164, Met165, Leu167, Thr190 and Gln192 (N = 12)ZINC000052955754Ergotamine![](fx8_lrg.gif)−9.5O1.....N(Gly143)\
O4.....N(Gly143)Thr25, His41, Met49, Asn142, Cys145, His164, Met165, Glu166 and Gln189 (N = 9)ZINC000006716957Nilotinib![](fx9_lrg.gif)−9.4N4.....OD(Asn142) \[3.03 Å\]\
N1.....O(His164) \[3.15 Å\]Thr25, His41, Cys44, Met49, Phe140, Cys145, His163, Met165, Glu166 and Gln189 (N = 10)ZINC000013831130Raltegravir![](fx10_lrg.gif)−9.2O4.....O(His41) \[2.95 Å\]\
O2.....N(Cys145) \[3.25 Å\]\
N5.....OD1 (Asn142) \[2.83 Å\]Thr25, Thr26, Leu27, Cys44, Met49, Leu141, Gly143, Asp187, Arg188 and Gln189, (N = 10)ZINC000003978005Dihydroergotamine![](fx11_lrg.gif)−9.2O4.....N(Ser144) \[3.34 Å\]\
O4.....N(Gly143) \[2.67 Å\]\
O1.....N(Gly143) \[2.98 Å\]Thr25, Leu27, His41, Cys44, Met49, Asn142, Cys145, His164, Met165, Glu166 and Gln189 (N = 11)Control (G85)SG85![](fx12_lrg.gif)−7.9O19.....N(Cys145) \[3.20 Å\]\
O19.....SG(Cys145) \[3.28 Å\]\
N49.....OE1(Gln189) \[2.89 Å\]\
O47.....N(Glu166) \[3.02 Å\]Thr25, Thr26, His41, Met49, Phe140, Leu141, Asn142, Gly143, Ser144, His163, His164, Met165, Asp187, Thr190, Ala191 and Gln192 (N = 16)Fig. 2Binding conformation and molecular interaction (compounds are represented as green sticks and key interacting residues are displayed in thin red wireframe representation) between SARS-CoV M^pro^ lead compounds and. (A) Saquinavir (ZINC000026985532) (B) inhibitor SG85 (G85). The hydrophobic interactions are indicated by red arcs with radiating spikes and green dashed lines correspond to hydrogen bonds.

The top 5 leads for the third target-MERS-CoV M^pro^ were found to be Ergotamine (ZINC000052955754), Ak-Fluor (ZINC000003860453), Avodart (ZINC000003932831), Dihydroergotamine (ZINC000003978005) and Saquinavir (ZINC000026664090) with binding energies of −9.6 kcal/mol, −9.4 kcal/mol, −9.3 kcal/mol, −9.3 kcal/mol, −9.3 kcal/mol and −8.1 kcal/mol respectively ([Table 3](#t0015){ref-type="table"} ). The best lead molecule- Ergotamine (ZINC000052955754) binds to a region within the Cys148-His41 catalytic dyad pocket and establishes one hydrogen bond with side chain sulphur (SG) atom of Cys148 and hydrophobic interactions with twelve important residues (Met25, His41, Leu49, Asp190, Leu144, Cys145, Met168, Glu169, Lys191, Gln192, Val193 and His194) ([Fig. 3](#f0015){ref-type="fig"} A). The control, inhibitor GC813 (AW4) shows binding energy of −8.1 kcal/mol with the target enzyme and the molecular interaction is reinforced by seven hydrogen bonds (four hydrogen bonds with the backbone atoms oxygen (O) atom of Leu144, nitrogen (N) atom of Ser147, nitrogen (N) atom of Gly146 and nitrogen (N) atom of Cys148 and three hydrogen bonds with side-chain oxygen (OG) atom of Ser147, sulphur (SG) atom of Cys148 and oxygen (OE1) atom of Gln192) and hydrophobic interactions via eleven residues- Met25, His41, Leu49, Tyr54, Cys145, Met168, Glu169, Asp190, Lys191, Val193 and His194 ([Fig. 3](#f0015){ref-type="fig"}B).Table 3Binding energy scores and molecular interactions between top 5 leads and MERS-CoV M^pro^. The figures in bracket indicate the hydrogen bond length.ZINC IDCommon NameStructureBinding Energy (kcal/mol)Molecular InteractionsHydrogen bondsHydrophobic interactionsZINC000052955754Ergotamine![](fx13_lrg.gif)−9.6O3.....SG(Cys148) \[3.23 Å\]Met25, His41, Leu49, Leu144, Cys145, Met168, Glu169, Asp190, Lys191, Gln192, Val193 and His194 (N = 12)ZINC000003860453Ak-Fluor![](fx14_lrg.gif)−9.4O2.....NE2(His41) \[3.01 Å\]\
O5.....O(Leu144) \[3.23 Å\]\
O5.....NE2(His166) \[3.20 Å\]\
O5.....OG(Ser147) \[3.13 Å\]Met25, Phe143, Cys145, Gly146, Cys148, Gln167, Met168, Glu169, Lys191 and Gln192 (N = 10)ZINC000003932831Avodart![](fx15_lrg.gif)−9.3NilHis41, Leu49, Leu144, Cys145 Gln167, Met168, Glu169, Asp190, Lys191 and Gln192 (N = 10)ZINC000003978005Dihydroergotamine![](fx16_lrg.gif)−9.3O1.....SG(Cys145) \[3.35 Å\]Met25, His41, Leu49, Leu144, Cys148, Met168, Glu169, Asp190, Lys191, Gln192 and His194 (N = 11)ZINC000026664090Saquinavir![](fx17_lrg.gif)−9.3O2.....SG(Cys145) \[3.21 Å\]\
O3.....NE2(His41) \[2.97 Å\]\
N3.....OE1(Gln192) \[3.13 Å\]\
N5.....OE1 (Gln192) \[2.99 Å\]\
N4.....O (Asp190) \[3.18 Å\]Met25, Thr26, Leu49, Phe143, Leu144, Gly146, Ser147, Cys148, His166, Met168, Glu169 and Lys191 (N = 12)Control (AW4)GC813![](fx18_lrg.gif)−8.1N13.....O(Leu144) \[2.80 Å\]\
N13.....OG(Ser147) \[3.14 Å\]\
O16.....N(Ser147) \[2.99 Å\]\
O16.....SG(Cys148) \[3.17 Å\]\
O16.....N(Cys148) \[3.10 Å\]\
O16.....N(Gly146) \[3.26 Å\]\
N03.....OE1(Gln192) \[2.80 Å\]Met25, His41, Leu49, Tyr54, Cys145, Met168, Glu169, Asp190, Lys191, Val193 and His194 (N = 11)Fig. 3Binding conformation and molecular interaction (compounds are represented as green sticks and key interacting residues are displayed in thin red wireframe representation) between MERS-CoV M^pro^ and lead compounds and (A) Ergotamine (ZINC000052955754) (B) inhibitor GC813 (AW4). The hydrophobic interactions are indicated by red arcs with radiating spikes and green dashed lines correspond to hydrogen bonds.

The molecules- Dihydroergotamine (ZINC000003978005) and Ergotamine (ZINC000052955754) were identified to be common leads interacting with all the three target enzymes with good binding energies and the favourable number of hydrogen bonds and hydrophobic interactions. Both Ergotamine and its derivative, Dihydroergotamine have been used in clinical practice for the treatment of acute migraine for many years. Both the drugs exhibit complex modes of pharmacological binding with several receptors such as 5-HT (5-hydroxytryptamine), dopamine and noradrenaline receptors and are potent vasoconstrictors ([@b0010], [@b0105]).

4. Conclusion {#s0040}
=============

Understanding the global health emergency and the immediate need for drugs and vaccines for the treatment of coronaviral infection, the present study is undertaken to identify promising inhibitors for main protease enzymes of coronaviruses through molecular docking approach. Our study suggests that anti-migraine drugs such as Ergotamine (ZINC000052955754) and its derivative, Dihydroergotamine (ZINC000003978005) are the most potent lead molecules which can be taken for further studies in wet lab experimentations.
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